Patricia Houle

With bachelor degrees in biochemistry and over 14 years of experience in Clinical Research with therapeutic indication focus in Oncology, Ms. Houle has strong experience with sites management, Principal Investigators/Physicians/Medical Monitors interactions, inspections/audit/ QA/CAPA processes, sponsor representations, clinical departments comprehension from RSU/SSU to clinic phase I, II, III studies, source data verification/DTE monitoring, Investigational Product management activities and regulatory documentations managements/quality/compliance in the therapeutic areas of Oncology, Neurology, Gastrointestinal, Infectious Diseases, Women Health and Allergy / Respiratory. Ms. Houle has monitored on several indications including pediatric Acute Lymphoblastic Leukemia , Advanced or Metastatic Breast Cancer, advanced renal cell carcinoma, unresectable advance /metastatic melanoma, advanced solid tumors, Merkel cell carcinoma, Small Cell Carcinoma of Lung, Eosinophilic Esophagitis, Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP), Crohn’s diseases, Ulcerative Colitis, Vaginitis, Multiples Sclerosis, Influenza, Respiratory Tract Infection, Chronic Pain, Allergy Rhinitis, Ischemic Stroke, Paroxysmal Nocturnal Hemoglobinuria (PNH) and Covid-19 Vaccine. Ms. Houle completed numerous clinical research training courses (including but not restricted to ICH GCP, Health Canada part C Division 5) and continues to expand her knowledge with continuing education. Ms. Houle ensure compliance to ICG GCP by working with all departments/groups to protects the rights, safety and welfare of human subjects and improves quality of data and accessibility of drugs.